Kevin Ali | Source | Chief Executive Officer at Organon
Kevin Ali
Kevin Ali is the CEO and board member of Organon, a global healthcare company with the vision of creating a better and healthier every day for every woman around the world. Kevin led the formation of Organon in 2021 to address the significant health issues that women face and deliver impactful solutions all over the world.
-
A simple device could prevent thousands of maternal deaths. Why did it take so long to get to market?
The journey of the Jada System is a parable of the business of women's health care.
Article -
CEO Kevin Ali Marks Organon’s Progress In First Post-Spin Year
A year after Organon spun out of Merck, the company has delivered on its financial guidance, generated double-digit biosimilars sales growth and executed six deals to grow in women’s health.
Article -
Building a New Legacy
Pharm Exec catches up with longtime Merck international business leader Kevin Ali to find out how Organon, the ambitious Merck spinoff he formed just over a year ago, has fared so far in delivering on its mission of creating a global leader and difference-maker in women’s health.
Article
-
Organon
Chief Executive Officer